Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page
- ChecktodayChange DetectedThe study's external identifiers now include an NIH grant/contract entry for 2023, reflecting NIH funding attribution.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedInstead of the trial details, the page now displays a 500 error indicating the service is unavailable. This renders the TROPHY U-01 study record on ClinicalTrials.gov inaccessible until the issue is resolved.SummaryDifference20%

- Check22 days agoNo Change Detected
- Check29 days agoChange Detected- The page revision label changed from v3.6.3 to v3.6.4, indicating a small update to the version history; this does not modify content or functionality.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a new editorial update to the page in the system.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a maintenance patch to the page. It appears to represent a minor update rather than a substantive content change.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded new sections for joining and help resources (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) to assist users. Intervention/Treatment heading formatting was standardized and the revision tag was updated from v3.5.5 to v3.6.0 to reflect the latest changes.SummaryDifference0.2%

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.